Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0970 per EA under NDC 65862069405. Its NADAC has been published 507 times since Dec 9, 2015.
FDA first approved this application on May 29, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862069405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203974FDA Approved
5/29/2015
TE Code
AB
On Market Since
5/29/2015
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 507 times since Dec 9, 2015, and over the history we have for it it has declined 59.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0970 per EA |
|---|---|
| All-time high | $0.2777 (Sep 14, 2016) |
| All-time low | $0.0739 (May 22, 2024) |
| Median price | $0.1391 |
| Average price | $0.1595 |
| Largest weekly change | +36.9% (May 22, 2019) |
| Weeks tracked | 507 |
| Tracking since | Dec 9, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+2.9%
5Y
-15.6%
All
-59.5%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0970 per EA (NDC 65862069405), effective Aug 20, 2025.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has declined 59.5%. It has been tracked across 507 weekly CMS publications since Dec 9, 2015.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Dec 9, 2015, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0739 (May 22, 2024) to a high of $0.2777 (Sep 14, 2016), with a median of $0.1391 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METRONIDAZOLE 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 65862069405) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.